NeoGenomics

About:

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.

Website: http://www.neogenomics.com

Twitter/X: NeoGenomics

Top Investors: RTW Investments, Woodline Partners, Soleus Capital, Avidity Partners, Janus Henderson Investors

Description:

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.

Total Funding Amount:

$926M

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Fort Myers, Florida, United States

Founded Date:

1998-10-29

Contact Email:

hr(AT)neogenomics.com

Founders:

Number of Employees:

501-1000

Last Funding Date:

2021-05-05

IPO Status:

Public

© 2025 bioDAO.ai